Hemophilia & Von Willebrand Disease In Children: Factor 8, Factor 9, Factor VII, Factor IX, Clotting Factor Inhibitors, Factor Replacement Therapy | EB Medicine
TOC Will Appear Here

Hemophilia And Von Willebrand Disease In Children: Emergency Department Evaluation And Management

Already purchased this course?
Log in to read.
Purchase a subscription

Price: $449/year

140+ Credits!

Money-back Guarantee
Publication Information

Kevin R. Schwartz, MD; Max Rubinstein, MD

Publication Date

September 2, 2015

CME Expiration Date

October 1, 2018

Get Permission

CME Information

Related Articles

The Use Of Blood Products In The Critically Ill Patient: Indications And Risks - EM Critical Care - January 2014

Evidence-Based Emergent Management Of Bleeding Disorders - Pediatric Emergency Medicine Practice - August 2011 (FREE)

Get A Sample Issue Of Emergency Medicine Practice
Enter your email to get your copy today! Plus receive updates on EB Medicine every month.
Please provide a valid email address.